"Incidence of transient congenital hypothyroidism due to maternal thyrotropin receptorblocking antibodies in over one million babies" (1996). Open Access Articles. 987.
1. Labelled glycine and/or 6-aminolaevulinic acid (ALA) were administered to a child with congenital erythropoietic porphyria (Giinther's disease), to three normal children and to three patients with erythropoietic protoporphyria.2. The utilization of [I5N]ALA for the synthesis of faecal 'urobilin' in the congenital erythropoietic patient was normal.3. This suggests there is no significant increase of hepatic bile-pigment formation in congenital erythropoietic porphyria.4. The utilization of glycine for synthesis of faecal 'urobilin' and protoporphyrin in all three patients with erythropoietic protoporphyria was increased. There was a similarly high utilization of [4-14C]ALA administered either orally or intravenously to one of the patients.5. The utilization of [4-14C]ALA was not affected by phlebotomy. 6. Utilizations of both ALA and glycine for free erythrocyte and plasma protoporphyrins were low.7. This study provides further evidence that in erythropoietic protoporphyria there is a greatly increased hepatic contribution to the early labelled fraction of bile pigment and that in this disease the excessive protoporphyrin is formed mainly in the liver.Porphyrias are classified as erythropoietic or hepatic according to the apparent site of the primary defect of porphyrin metabolism. In congenital erythropoietic porphyria (CEP;
scite is a Brooklyn-based organization that helps researchers better discover and understand research articles through Smart Citations–citations that display the context of the citation and describe whether the article provides supporting or contrasting evidence. scite is used by students and researchers from around the world and is funded in part by the National Science Foundation and the National Institute on Drug Abuse of the National Institutes of Health.